Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol

BACKGROUND: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MSCs; ‘adult stem cells’) could represent a promisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalu, Manoj M, Moher, David, Marshall, John, Fergusson, Dean, Mei, Shirley HJ, Macleod, Malcolm, Griffin, Gilly, Turgeon, Alexis F, Rudnicki, Michael, Fishman, Jason, Avey, Marc T, Skidmore, Becky, Grimshaw, Jeremy M, Stewart, Duncan J, Singh, Kavita, McIntyre, Lauralyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046388/
https://www.ncbi.nlm.nih.gov/pubmed/24887266
http://dx.doi.org/10.1186/2046-4053-3-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046388/
https://www.ncbi.nlm.nih.gov/pubmed/24887266
http://dx.doi.org/10.1186/2046-4053-3-48

Ejemplares similares